Recent developments in systems biology and genetic engineering toward design of vaccines for TB
Crit Rev Biotechnol; October 12, 2021
Kathleen Davis, PhD, Postdoctoral Scholar Working on Adapting Drug Combination Testing of Clinical Isolates
Postdoctoral Scholar working to identify antibiotic and small molecule combinations that function against problematic community and hospital-acquired pathogens; Working on adapting drug combination testing of clinical isolates
Phage Prophylaxis of Cholera – Tufts University’s Andrew Camilli, PhD
Bacteriophages are viruses that specifically target and kill bacteria, preventing bacterial infections, and Dr. Andrew Camilli and his lab study the bacteriophages that kill V. cholerae. Dr. Camilli is also co-founder and scientific advisor to PhagePro, Inc., a Boston-based startup aiming
Host-Informed Therapies for the Treatment of Pneumococcal Pneumonia
Trends Mol. Micro; October 1, 2021